Isolation and characterization of a subset of erythropoietin glycoforms with cytoprotective but minimal erythropoietic activity

Biotechnology Progress

Volumn 27, Issue 4, 2011, Pages 1018-1028

  Mattio, Mónica ^a   Ceaglio, Natalia ^a   Oggero, Marcos ^a   Perotti, Norma ^a   Amadeo, Ignacio ^b   Orozco, Gustavo ^b   Forno, Guillermina ^b   Kratje, Ricardo ^a   Etcheverrigaray, Marina ^a  

^a UNIVERSIDAD NACIONAL DEL LITORAL   (Argentina)

^b Zelltek SA   (Argentina)

Author keywords

Cytoprotection; Erythropoietin; Isoforms

Indexed keywords

BIOLOGICAL CHARACTERIZATION; CELL LINES; CEREBRO SPINAL FLUIDS; CHROMATOGRAPHIC PROCEDURE; CYTOPROTECTION; ERYTHROPOIETIN; GLYCOFORMS; IN-VITRO; IN-VIVO; INTRAVENOUS ADMINISTRATION; ISOFORMS; ISOLATION AND CHARACTERIZATION; NEUROLOGICAL DISEASE; NEURONAL DAMAGE; NEUROPROTECTIVE AGENTS; NEUROTROPHIC; PARKINSON'S DISEASE; PERIPHERAL NEUROPATHY; POSTINJECTION; POTENTIAL DRUG; RETINAL DAMAGE; SIDE EFFECT; SINGLE PROCESS; SPINAL CORD COMPRESSION; THERAPEUTIC APPLICATION; TRAUMATIC BRAIN INJURIES;

CELL CULTURE; DISEASES; TISSUE;

BRAIN;

ERYTHROPOIETIN; ISOPROTEIN; NEUROPROTECTIVE AGENT;

ANIMAL; ARTICLE; CELL SURVIVAL; CHO CELL; CYTOLOGY; DRUG EFFECT; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HAMSTER; HUMAN; ISOELECTRIC FOCUSING; ISOLATION AND PURIFICATION; METABOLISM; NERVE CELL; PC12 CELL; POLYACRYLAMIDE GEL ELECTROPHORESIS; RAT; WISTAR RAT;

ANIMALS; CELL SURVIVAL; CHO CELLS; CRICETINAE; ELECTROPHORESIS, POLYACRYLAMIDE GEL; ENZYME-LINKED IMMUNOSORBENT ASSAY; ERYTHROPOIETIN; FEMALE; HUMANS; ISOELECTRIC FOCUSING; NEURONS; NEUROPROTECTIVE AGENTS; PC12 CELLS; PROTEIN ISOFORMS; RATS; RATS, WISTAR;

RATTUS;

EID: 79961025728     PISSN: 87567938     EISSN: 15206033     Source Type: Journal    
DOI: 10.1002/btpr.633     Document Type: Article

References (42)

1. Fisher JW. Erythropoietin: physiology and pharmacology update. Exp Biol Med. 2003; 228: 1-14.
2. Juul SE, Anderson DK, Li Y, Christensen RD. Erythropoietin and erythropoietin receptor in the developing human central nervous system. Pediatr Res. 1998; 43: 40-49.
3. Morishita E, Masuda S, Nagao M, Yasuda Y, Sasaki R. Erythropoietin receptor is expressed in rat hippocampal and cerebral cortical neurons, and erythropoietin prevents in vitro glutamate-induced neuronal death. Neuroscience. 1997; 76: 105-116.
4. Nagai A, Nakagawa E, Choi HB, Hatori K, Kobayashi S, Kim SU. Erythropoietin and erythropoietin receptors in human CNS neurons, astrocytes, microglia, and oligodendrocytes grown in culture. J Neuropathol Exp Neurol. 2001; 60: 386-392.
5. Sugawa M, Sakurai Y, Sakurai Y, Ishikawa-Ieda Y, Suzuki H, Asou H. Effects of erythropoietin on glial cell development, oligodendrocyte maturation and astrocyte proliferation. Neurosci Res. 2002; 44: 391-403.
6. Rabie T, Marti HH. Brain protection by erythroietin: a manifold task. Physiology. 2008; 23: 263-274.
7. Brines M, Grasso G, Fiodarliso F, Sfacteria A, Ghezzi P, Fratelli M, Latini R, Xie QW, Smart J, Su-Rick CJ, Pobre E, Diaz D, Gomez D, Hand C, Coleman T, Cerami A. Erythropoietin mediates tissue protection through an erythropoietin and a common beta-subunit heteroreceptor. Proc Natl Acad Sci USA. 2004; 101: 14907-14912.
8. Murphy JM, Young IG. IL-3, IL-5 and GM-CSF signalling: crystal structure of the human beta-common receptor. Vitam Horm. 2006; 74: 1-30.
9. Wiessner C, Allegrini PR, Ekatodramis D, Jewell UR, Stallmach T, Gassmann M. Increased cerebral infarct volumes in polyglobulic mice overexpressing erythropoietin. J Cereb Blood Flow Metab. 2001; 21: 857-864.
10. Stohlawetz PJ, Dzirlo L, Hergovich N, Lackner E, Mensik C, Eichler HG, Kabrna E, Geissler K, Jilma B. Effects of erythropoietin on platelet reactivity and thrombopoiesis in humans. Blood. 2000; 95: 2983-2989.
11. Konstantinopoulos PA, Karamouzis MV, Papavassiliou AG. Selective modulation of the erythropoietic and tissue-protective effects of erythropoeitin: time to reach the full therapeutic potential of erythropoietin. Biochim Biophys Acta. 2007; 1776: 1-9.
12. Leist M, Ghezzi P, Grasso G, Bianchi R, Villa P, Fratelli M, Savino C, Bianchi M, Nielsen J, Gerwien J, Kallunki P, Larsen AK, Helboe L, Christensen S, Pedersen LO, Nielsen M, Torup L, Sager T, Sfacteria A, Erbayraktar S, Erbayraktar Z, Gokmen N, Yilmaz O, Cerami-Hand C, Xie QW, Coleman T, Cerami A, Brines M. Derivatives of erythropoietin that are tissue protective but not erythropoietic. Science. 2004; 305: 239-242.
13. Erbayraktar S, Grasso G, Sfacteria A, Xie QW, Coleman T, Kreilgaard M, Torup L, Sager T, Erbayraktar Z, Gokmen N, Yilmaz O, Ghezzi P, Villa P, Fratelli M, Casagrande S, Leist M, Helboe L, Gerwein J, Christensen S, Geist MA, Pedersen LØ, Cerami-Hand C, Wuerth JP, Cerami A, Brines M. Asialoerythropoietin is a nonerythropoietic cytokine with broad neuroprotective activity in vivo. Proc Natl Acad Sci USA. 2003; 100: 6741-6746.
14. Mennini T, De Paola M, Bigini P, Mastrotto C, Fumagalli E, Barbera S, Mengozzi M, Viviani B, Corsini E, Marinovich M, Torup L, Van Beek J, Leist M, Brines M, Cerami A, Ghezzi P. Nonhematopoietic erythropoietin derivatives prevent motoneuron degeneration in vitro and in vivo. Mol Med. 2006; 12: 153-160.
15. Takeuchi M, Takasaki S, Shimada M, Kobata A. Role of sugar chains in the in vitro biological activity of human erythropoietin produced in recombinant chinese hamster ovary cells. J Biol Chem. 1990; 265: 12127-12130.
16. Tsuda E, Kawanishi G, Ueda M, Masuda S, Sasaki R. The role of carbohydrate in recombinant human erythropoeitin. Eur J Biochem. 1990; 188: 405-411.
17. Fukuda MN, Sasaki H, Lopez L, Fukuda M. Survival of recombinant erythropoietin in the circulation: the role of carbohydrates. Blood. 1989; 73: 84-89.
18. Masuda S, Okano M, Yamagishi K, Nagao M, Ueda M, Sasaki R. A novel site of erythropoietin production. Oxygen-dependent production in cultured rat astrocytes. J Biol Chem. 1994; 269: 19488-19493.
19. Kratje RB, Wagner R. Evaluation of production of recombinant human interleukin-2 in fluidized bed bioreactor. Biotechnol Bioeng. 1992; 39: 233-242.
20. Bradford MA. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 1976; 72: 248-254.
21. Laemmli UK. Cleavage of structural proteins during the assembly of the head bacteriophage T4. Nature. 1970; 227: 680-685.
22. European Pharmacopoeia 6th ed. Strasbourg: Council of Europe; 2008: 1813-1817.
23. Jourdian GW, Dean L, Roseman S. The sialic acids XI. A periodate-resorcinol method for the quantitative estimation of free sialic acids and their glycosides. J Biol Chem. 1971; 246: 430-435.
24. Komatsu N, Yamamoto M, Fujita H, Miwa A, Hatake K, Endo T, Okano H, Katsube T, Fukumaki Y, Sassa S. Establishment and characterization of an erythropoietin-dependent subline, UT-7/Epo, derived from human leukemia cell line, UT-7. Blood. 1993; 82: 456-464.
25. Kitamura T, Tange T, Tersawa T, Chiba S, Kuwaki T, Miyagawa K, Piao YF, Miyazono K, Urabe A, Takaku F. Establishment and characterization of a unique human cell line that proliferates dependently on GM-CSF, IL-3 or erythropoietin. J Cell Physiol. 1989; 140: 323-334.
26. Shargel L, Wu-Pong S, Yu ABC. Applied Biopharmaceutics and Pharmacokinetics. New York, NY: McGraw-Hill Medical Publishing Division; 2005.
27. Llop E, Gutiérrez-Gallego R, Segura J, Mallorquí J, Pascual JA. Structural analysis of the glycosylation of gene-activated erythropoietin (epoetin delta, Dynepo). Anal Biochem. 2008; 383(2): 243-254.
28. Egrie JC, Browne JK. Development and characterization of novel erythropoiesis stimulating protein (NESP). Nephrol Dial Transplant. 2001; 16 (Suppl 3): 3-13.
29. Darling RJ, Kuchibhotla U, Glaesner W, Micanovic R, Wither DR, Beals JM. Glycosylation of erythropoeitin affects receptor binding kinetics: role of electrostatic interactions. Biochemistry. 2002; 41: 14524-14531.
30. Wasley LC, Timony G, Murtha P, Stoudemire J, Dorner AJ, Caro J, Krieger M, Kaufman RJ. The importance of N- and O-linked oligosaccharides for the biosynthesis and in vitro and in vivo biologic activities of erythropoietin. Blood. 1991; 77: 2642-2632.
31. Lim VS. Recombinant human erythropoietin in predialysis patients. Am J Kidney Dis. 1991; 18: 34-37.
32. Wagner KF, Katschinski DM, Hasegawa J, Schumacher D, Meller B, Gembruch U, Schramm U, Jelkmann W, Gassmann M, Fandrey J. Chronic inborn erythrocytosis leads to cardiac dysfunction and premature death in mice overexpresssing erythropoietin. Blood. 2001; 15: 536-542.
33. Gooche CF, Gramer MJ, Andersen DC, Bahr JB, Rasmussen JR. The oligosaccharides of glycoproteins: factors affecting their synthesis and their influence on glycoprotein properties. Biotechnology. 1992; 9: 1347-1355.
34. Morell AG, Gregoriadis G, Scheinberg H. The role of sialic acid in determining the survival of glycoproteins in the circulation. J Biol Chem. 1971; 246: 1461-1467.
35. Brines M, Patel NSA, Villa P, Brines C, Mennini T, De Paola M, Erbayraktar Z, Erbayraktar S, Sepodes B, Thiemermann C, Ghezzi P, Yamin M, Hand CC, Xie QW, Coleman T, Cerami A. Nonerythropoietic, tissue-protective peptides derived from the tertiary structure of erythropoietin. Proc Natl Acad Sci USA. 2008; 105: 10925-10930.
36. Xenocostas A, Cheung WK, Farrel F, Zakszewski C, Kelley M, Lutynski A, Crump M, Lipton JH, Kiss TL, Lau CY, Messner HA. The pharmacokinetics of erythropoietin in the cerebrospinal fluid after intravenous administration of recombinant hyman erythropoeitin. Eur J Clin Pharmacol. 2005; 61: 189-195.
37. Brines M, Ghezzi P, Keenan S, Agnello D, de Lanerolle NC, Cerami C, Itri LM, Cerami A. Erythropoietin crosses the blood-brain barrier to protect against experimental injury. Proc Natl Acad Sci USA. 2000; 97: 10526-10531.
38. Yamaji R, Okada T, Moriya M, Naito M, Tsuruo T, Miyatake K, Nakano Y. Brain capillary endothelial cells express two forms of erythropoietin receptor mRNA. Eur J Biochem. 1996; 239: 494-500.
39. Banks WA, Jumbe NL, Farrel CL, Niehoff ML, Heatherington AC. Passage of erythropoietic agents across the blood-brain barrier: a comparison of human and murine erythropoietin and the analog darbepoetin alfa. Eur J Pharmacol. 2004; 505: 93-101.
40. Haviv R, Lindenboim L, Li H, Yuan J, Stein R. Need for caspases in apoptosis of trophic factor-deprived PC12 cells. J Neurosci Res. 1997; 50: 69-80.
41. Li G, Ma R, Huang C, Tang Q, Fu Q, Liu H, Hu B, Xiang J. Protective effect of erythropoietin on β-amiloid-induced PC12 cell death through antioxidant mechanisms. Neurosci Lett. 2008; 442: 143-147.
42. Boix J, Llecha N, Yuste VJ, Comella JX. Characterization of the cell death process induced by staurosporine in human neuroblastoma cell lines. Neuropharmacology. 1997; 36: 811-821.